| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Andrology, Vol 18, Issue 2 103-106, Copyright © 1997 by The American Society of Andrology
REVIEW |
J. L. Tenover
Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
The number and magnitude of studies involving testosterone-supplementation therapy in older men are limited. In addition, many studies to date have not been blinded or controlled, were reported in abstract form only, and had involved a variety of androgen-replacement regimens and outcomes measurements. Nonetheless, an overview of the data suggests there is real potential for supplementation therapy to improve bone mass and muscle mass and strength in this age group. Affects on mood, sexual function, and cognition are less clear but may be meaningful in certain men. Questions still remain, however, on the magnitude and longevity of the beneficial effects of testosterone supplementation in the older man and whether only certain subgroups of men would truly benefit from therapy. More importantly, the long-term risks of androgen therapy in this age group really are not known, especially in the areas of cardiovascular disease and prostate diseases. Presently, men who use androgen-supplementation therapy for age-related "testosterone deficiency" should consider this as a gamble.
This article has been cited by other articles:
![]() |
B. L. Marshall Climacteric Redux?: (Re)medicalizing the Male Menopause Men and Masculinities, April 1, 2007; 9(4): 509 - 529. [Abstract] [PDF] |
||||
![]() |
E. E. Pistilli, P. M. Siu, and S. E. Alway Interleukin-15 responses to aging and unloading-induced skeletal muscle atrophy Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1298 - C1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wald, R. B. Meacham, L. S. Ross, and C. S. Niederberger Testosterone Replacement Therapy for Older Men J Androl, March 1, 2006; 27(2): 126 - 132. [Full Text] [PDF] |
||||
![]() |
Testosterone Replacement Therapy for Male Aging: ASA Position Statement J Androl, March 1, 2006; 27(2): 133 - 134. [Full Text] [PDF] |
||||
![]() |
C. A. Orengo, L. Fullerton, and M. E. Kunik Safety and Efficacy of Testosterone Gel 1% Augmentation in Depressed Men With Partial Response to Antidepressant Therapy J Geriatr Psychiatry Neurol, March 1, 2005; 18(1): 20 - 24. [Abstract] [PDF] |
||||
![]() |
T. J. Doherty Invited Review: Aging and sarcopenia J Appl Physiol, October 1, 2003; 95(4): 1717 - 1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yin, H. Xu, Y. He, L. I. Kirkovsky, D. D. Miller, and J. T. Dalton Pharmacology, Pharmacokinetics, and Metabolism of Acetothiolutamide, a Novel Nonsteroidal Agonist for the Androgen Receptor J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1323 - 1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yin, W. Gao, J. D. Kearbey, H. Xu, K. Chung, Y. He, C. A. Marhefka, K. A. Veverka, D. D. Miller, and J. T. Dalton Pharmacodynamics of Selective Androgen Receptor Modulators J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1334 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Okun, W. M. McDonald, and M. R. DeLong Refractory Nonmotor Symptoms in Male Patients With Parkinson Disease Due to Testosterone Deficiency: A Common Unrecognized Comorbidity Arch Neurol, May 1, 2002; 59(5): 807 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Huhtaniemi and A. Bartke Perspective: Male Reproduction Endocrinology, June 1, 2001; 142(6): 2178 - 2183. [Full Text] [PDF] |
||||
![]() |
D. M. Keenan and J. D. Veldhuis Hypothesis testing of the aging male gonadal axis via a biomathematical construct Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1755 - R1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Margolese The Male Menopause and Mood: Testosterone Decline and Depression in the Aging Male--Is There a Link? J Geriatr Psychiatry Neurol, July 1, 2000; 13(2): 93 - 101. [Abstract] [PDF] |
||||
![]() |
D. C Gould, R. Petty, and H. S Jacobs For and against: The male menopause---does it exist? • For • Against BMJ, March 25, 2000; 320(7238): 858 - 861. [Full Text] |
||||
![]() |
B. T. Ameredes, J. F. Watchko, M. J. Daood, J. F. Rosas, M. P. Donahoe, and R. M. Rogers Growth Hormone Improves Body Mass Recovery with Refeeding after Chronic Undernutrition-Induced Muscle Atrophy in Aging Male Rats J. Nutr., December 1, 1999; 129(12): 2264 - 2270. [Abstract] [Full Text] |
||||
![]() |
R. Bross, M. Javanbakht, and S. Bhasin Anabolic Interventions for Aging-Associated Sarcopenia J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3420 - 3430. [Full Text] [PDF] |
||||
![]() |
H. Sternbach Age-Associated Testosterone Decline in Men: Clinical Issues for Psychiatry Am J Psychiatry, October 1, 1998; 155(10): 1310 - 1318. [Abstract] [Full Text] |
||||
![]() |
M. Bergendahl, J. A. Aloi, A. Iranmanesh, T. M. Mulligan, and J. D. Veldhuis Fasting Suppresses Pulsatile Luteinizing Hormone (LH) Secretion and Enhances Orderliness of LH Release in Young but Not Older Men J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1967 - 1975. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |